Abilita Therapeutics, Inc. · 3 days ago
Research Associate in Antibody Discovery
Abilita Therapeutics is an innovation-driven biotechnology start-up company focused on enabling the discovery and development of drugs targeting undruggable membrane proteins. They are seeking a skilled and motivated Research Associate in Antibody Discovery to assist with challenging discovery campaigns across multiple targets.
Responsibilities
Support antibody discovery efforts by executing laboratory experiments related to library generation and panning campaigns
Assist with workflows including antibody characterization, engineering, humanization, affinity maturation, and all other lead optimization activities
Perform basic tissue culture operations to maintain, transfect, and harvest mammalian cell biomass
Produce high-quality, reliable data and maintain accurate, detailed laboratory records
Operate and maintain the relevant equipment
Maintain close collaborative interactions with colleagues within the research group and regularly communicate progress to the team or supervisors
Qualification
Required
Bachelor's or Master's degree in Molecular Biology or a related field (REQUIRED)
Minimum of 5 years of molecular biology experience (REQUIRED)
Minimum of 2 years of antibody discovery experience in the laboratory (REQUIRED)
Proficiency with cloning, sequencing, and using basic molecular biology techniques (e.g. PCR, restriction enzymes)
Hands-on experience with phage display and/or yeast display
Demonstrated capability to independently design, implement, and troubleshoot experimental work in a laboratory
Strong organizational skills and attention to detail with a commitment to maintaining accurate lab records
Preferred
Experience with library construction is a plus
Experience with bioinformatics tools for sequence analysis is a plus
Benefits
Comprehensive benefits package
Stock options, giving you a significant stake in the success and growth of our company
Excellent career development opportunities
Company
Abilita Therapeutics, Inc.
Abilita Therapeutics is a biotechnology company focused on redefining the druggable landscape for multi-span membrane proteins, including G Protein Coupled Receptors (GPCRs), transporters and ion channels.
Funding
Current Stage
Early StageTotal Funding
$7.5MKey Investors
Two Bear Capital
2023-02-21Series Unknown· $7.5M
Recent News
Google Patent
2025-02-10
2025-02-10
2025-02-10
Company data provided by crunchbase